Friday, May 13th, 2016 - WiseGuyReports

About Respiratory Ailments

Asthma, COPD, allergic rhinitis, pulmonary hypertension, cystic fibrosis, and IPF are some of the major respiratory diseases. Among these, asthma and COPD are the most prevalent worldwide. Environmental pollution, changing lifestyles, and hereditary factors are some of the common causes of respiratory diseases. Intranasal corticosteroids, antihistamines, immunosuppressants, bronchodilators, and leukotriene antagonists are the respiratory medicines that are commonly used for the treatment of mild-to-moderate respiratory diseases. However, the choice of drug depends on the type and severity of the disease.

Technavio’s analysts forecast the global respiratory drugs market to grow at a CAGR of 6.48% during the period 2016-2020.

Complete report details @ https://www.wiseguyreports.com/reports/global-resipiratory-drugs-market-2016-2020-resipiratory-drugs-market-2016-2020

 

Covered in this report 
The report covers the present scenario and the growth prospects of the global respiratory drugs market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of prescription and over-the-counter (OTC) drugs used to treat respiratory diseases.

The market is divided into the following segments based on geography: 
• Americas 
• APAC 
• EMEA

Technavio's report, Global Respiratory Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors 
• AstraZeneca 
• Boehringer Ingelheim 
• F.Hoffman La-Roche 
• GlaxoSmithKline 
• Merck 
• Novartis

Request a sample report @ https://www.wiseguyreports.com/sample-request/global-resipiratory-drugs-market-2016-2020-resipiratory-drugs-market-2016-2020    

 

Other prominent vendors 
• Abbott 
• Actavis 
• Afferent Pharmaceuticals 
• Alere 
• Almirall 
• Amgen 
• AptarGroup 
• Astellas 
• Aurobindo 
• Axis Shield 
• Baxter 
• Bayer 
• Biogen 
• Biotest 
• Bristol-Myers Squibb 
• Chiesi Farmaceutici 
• Cipla 
• Cytos 
• Dainippon Sumitomo 
• Dr. Reddy's Laboratories 
• FibroGen 
• Gilead Sciences 
• Glenmark 
• GNI Group Ltd 
• Horizon Pharma 
• ImmuneWorks 
• MediciNova 
• MedImmune 
• Mylan 
• Ono Pharmaceutical 
• Orchid Chemicals and Pharmaceuticals 
• Perrigo 
• Pfizer 
• Promedior 
• Prometheus 
• ProMetic Life Sciences 
• Ranbaxy 
• Rottapharm Madaus 
• Sanofi 
• Shionogi 
• Siemens Healthcare Diagnostics 
• Skyepharma 
• Sosei 
Sunovion 
• Takeda Pharmaceutical 
• Teva 
• Theravance 
• United Therapeutics 
• Vectura 
• Vertex 
• Zai Lab

Market driver 
• Rise in prevalence of respiratory diseases 
• For a full, detailed list, view our report

Market challenge 
• Unknown etiology of asthma and idiopathic pulmonary fibrosis 
• For a full, detailed list, view our report

Market trend 
• Use of biologics 
• For a full, detailed list, view our report

Key questions answered in this report 
• What will the market size be in 2020 and what will the growth rate be? 
• What are the key market trends? 
• What is driving this market? 
• What are the challenges to market growth? 
• Who are the key vendors in this market space? 
• What are the market opportunities and threats faced by the key vendors? 
• What are the strengths and weaknesses of the key vendors?

Make an enquiry before buying this Report @ https://www.wiseguyreports.com/enquiry/global-resipiratory-drugs-market-2016-2020-resipiratory-drugs-market-2016-2020     

 

Table of content

PART 01: Executive summary 
• Highlights 
PART 02: Scope of the report 
• Market overview 
• Top-vendor offerings 
PART 03: Market research methodology 
• Research methodology 
• Economic indicators 
PART 04: Introduction 
• Key market highlights 
PART 05: Overview: Respiratory diseases 
• Asthma 
• COPD 
• Allergic rhinitis 
• Pulmonary hypertension 
• Cystic fibrosis 
• IPF 
• US FDA-approved respiratory drugs 
PART 06: Pipeline analysis 
• Information on some pipeline candidates 
PART 07: Market landscape 
• Five forces analysis 
PART 08: Market segmentation by class of drugs 
• Bronchodilators 
• Leukotriene antagonists 
• Mast cell stabilizers 
• Immunosuppressants 
• Combination of LABA/ICS 
• Tyrosine kinase inhibitors 
• Antifibrotic agents 
• Antihistamines 
• Endothelin (ET) receptor antagonist 
• Prostacyclin analogs 
• Phosphodiesterase inhibitors 
• Soluble guanylate cyclase (sGC) stimulators 
PART 09: Market segmentation by disease 
• Global asthma drugs market 
• Global COPD drugs market 
• Global allergic rhinitis drugs market 
• Global pulmonary hypertension drugs market 
• Global cystic fibrosis drugs market 
• Global IPF drugs market 
PART 10: Geographical segmentation 
• Global respiratory drugs market by geography 2015-2020 
• Respiratory drugs market in Americas 
• Respiratory drugs market in EMEA 
• Respiratory drugs market in APAC 
PART 11: Market drivers 
• Promising late-stage pipeline molecules 
• Rise in prevalence of respiratory diseases 
• Increase in older adult population 
• High usage of tobacco 
• Increase in environmental pollution 
PART 12: Impact of drivers 
PART 13: Market challenges 

• Multiple patent expiries 
• Unknown etiology of asthma and IPF 
• Low diagnosis rates 
• Adverse effects of drugs 
• Increased preference for CAM 
PART 14: Impact of drivers and challenges 
PART 15: Market trends 

• Increasing awareness about respiratory diseases 
• Patient assistance programs 
• Usage of biologics 
• Self-medication using OTC products 
• Strategic alliances 
PART 16: Vendor landscape 
• Competitive scenario 
• Market share analysis 2015 
• AstraZeneca 
• Boehringer Ingelheim 
• F. Hoffmann-La Roche 
• GlaxoSmithKline 
• Merck 
• Novartis 
• Other prominent vendors 
PART 17: Appendix 
• List of abbreviations 
PART 18: Explore Technavio 

Buy this report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=466194

 

Contact US:

NORAH TRENT

Partner Relations & Marketing Manager

[email protected]

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)          

 

File Library

Contact Profile

WiseGuyReports


Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

Our Market Research Reports and Consulting Services 

Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories. The Wise Guy Reports team prides itself in being the chosen source for market research reports, report customizations services, and other ancillary services such as a Newsletter service and corporate service for large organizations.

Hundreds of large and small organizations across virtually every industry sector worldwide are currently reaping rich dividends from the sharp insights provided by market research reports sourced through Wise Guy Reports. 

Gaining an insight into emerging trends, opportunities and potential threats is key to long-term sustenance in a competitive environment. The handpicked collection of market research reports on Wise Guy Reports is centred on this proven principle.


Norah Trent
P: +44 208 133 9349
M: +1 646 845 9349
W: www.wiseguyreports.com/

Keywords

Resipiratory Drugs market trend, Resipiratory Drugs market segmentation, Resipiratory Drugs market analysis, Resipiratory Drugs market parameters, Resipiratory Drugs industry forecast, Resipiratory Drugs market size, Resipiratory Drugs market share, Resip

Categories

Newsrooms

Sharing

More Formats